2 mins

Scopio on the future of telehematology

Through full-field digital cell morphology, Scopio Labs’ technology can automate the analysis of tens of thousands of cells at a time. This could mean bringing earlier detection and diagnosis of cancers, infections, and other diseases, expediting patients’ access to better care and life-saving treatments. Erez Na’aman, co-founder and CTO of Scopio Labs, tells us about the technology and its potential.
Link to full article

Scopio on the future of telehematology

Experience high resolution digital imaging and AI-driven full-field analysis

Book a demo